🇺🇸 US

ALNY earnings report dates and EPS history (Alnylam Pharmaceuticals, Inc.)

Quick answer

Alnylam Pharmaceuticals, Inc. (ALNY) reported diluted EPS of $1.21 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-07-30. Its last four 10-Q/10-K filings were on 2026-07-30, 2026-02-12, 2025-10-30, 2025-07-31.

✓ SEC EDGAR XBRL company facts (10-K/10-Q filings)

Data as of 2026-07-30. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)

Period endPeriodFormSEC filing dateDiluted EPS
2026-06-30Quarter10-Q2026-07-30$1.21
2025-12-31Full year10-K2026-02-12$2.33
2025-09-30Quarter10-Q2025-10-30$1.84
2025-06-30Quarter10-Q2025-07-31$-0.51
2025-03-31Quarter10-Q2025-05-01$-0.44
2024-12-31Full year10-K2025-02-13$-2.18
2024-09-30Quarter10-Q2024-10-31$-0.87
2024-06-30Quarter10-Q2024-08-01$-0.13
2024-03-31Quarter10-Q2024-05-02$-0.52
2023-12-31Full year10-K2024-02-15$-3.52
2023-09-30Quarter10-Q2023-11-02$1.15
2023-06-30Quarter10-Q2023-08-03$-2.21
2023-03-31Quarter10-Q2023-05-04$-1.40
2022-12-31Full year10-K2023-02-23$-9.30
2022-09-30Quarter10-Q2022-10-27$-3.32
2022-06-30Quarter10-Q2022-07-28$-2.29

Related

Last updated 2026-10-16. Data only, not financial or tax advice.